A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT)
Clinical trial NCT04105335 · COMPLETED
Trial details
- NCT number
- NCT04105335
- Sponsor
- Mina Alpha Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2025-01-25
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.